Clinical Data Shares Rise 8 Percent in Advance of Stock Split

Sep 28, 2007

NEW YORK (GenomeWeb News) - Clinical Data's share price climbed 8 percent to $39 a share in late-morning trading today, reaching a new 52-week high.

Earlier this month, the company authorized a 3-for-2 stock split for shareholders of record as of Sept. 24. The new shares will be distributed Oct. 1.

Clinical Data’s shares are up more than 12 percent for the week beginning Sept. 24.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Here We Are Again

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

In the Pink

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

All Tied Up in a Bow

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

This Week in PNAS

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

Main menu